Capecitabine, DNA/RNA Synthesis Inhibitor

Capecitabine is an oral proagent that is converted to its active metabolite, 5-FU, by thymidine phosphorylase. - Mechanism of Action & Protocol.

TAS1553, a small molecule subunit interaction inhibitor of ribonucleotide reductase, exhibits antitumor activity by causing DNA replication stress

5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition - ScienceDirect

5-FU (5-Fluorouracil), 99.97%(HPLC), In Stock

Why Great Mitotic Inhibitors Make Poor Cancer Drugs: Trends in Cancer

Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy, Journal of Hematology & Oncology

Capecitabine API Manufacturer and Supplier

Genes, Free Full-Text

Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients

Capecitabine